{"id":348380,"date":"2019-03-28T06:50:04","date_gmt":"2019-03-28T06:50:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=348380"},"modified":"2019-03-28T06:50:04","modified_gmt":"2019-03-28T06:50:04","slug":"applicationtoperson-a2p-sms-and-api-market-insights-2019-global-competitors-share-growth-and-future-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/applicationtoperson-a2p-sms-and-api-market-insights-2019-global-competitors-share-growth-and-future-forecast-to-2025_348380.html","title":{"rendered":"Application-to-Person (A2P) SMS and API Market Insights 2019, Global Competitors, Share Growth and Future Forecast to 2025"},"content":{"rendered":"
A2P SMS is currently used for various applications, such as providing event subsidies to end users, location-based opportunities, First-hand\/news news, promotional brands, voting contests, and transactional news for major industry vertical industries such as financial institutions and banks, games, travel and transportation, retail, healthcare facilities and hotels.<\/div>\n

A2P SMS messaging (also called enterprise or professional SMS) is the process of sending mobile messages from an application to a mobile user.<\/p>\n

The growth of the enterprise A2P SMS market<\/a> is mainly driven by the increase in the number of mobile phone service users and the shift from the desktop priority strategy to the mobile priority strategy.<\/p>\n

A2P SMS is currently used for various applications, such as providing event subsidies to end users, location-based opportunities, First-hand\/news news, promotional brands, voting contests, and transactional news for major industry vertical industries such as financial institutions and banks, games, travel and transportation, retail, healthcare facilities and hotels.<\/p>\n

Request Free Sample Report at <\/strong>https:\/\/www.wiseguyreports.com\/sample-request\/3869518-global-application-to-person-a2p-sms-and-api-market-research-report-2019<\/a><\/p>\n

The global Application-to-Person (A2P) SMS and API market is valued at 150 million US$ in 2018 is expected to reach 210 million US$ by the end of 2025, growing at a CAGR of 4.1% during 2019-2025.<\/p>\n

This report focuses on Application-to-Person (A2P) SMS and API volume and value at global level, regional level and company level. From a global perspective, this report represents overall Application-to-Person (A2P) SMS and API market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.<\/p>\n

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.<\/p>\n

 <\/p>\n

The following manufacturers are covered:<\/strong><\/p>\n

Twilio<\/p>\n

Syniverse Technologies<\/p>\n

Nexmo<\/p>\n

OpenMarket<\/p>\n

Tyntec<\/p>\n

Ogangi Corporation<\/p>\n

CLX Communications<\/p>\n

FortyTwo Telecom AB<\/p>\n

Beepsend AB<\/p>\n

 <\/p>\n

Segment by Regions<\/strong><\/p>\n

North America<\/p>\n

Europe<\/p>\n

China<\/p>\n

Japan<\/p>\n

 <\/p>\n

Segment by Type<\/strong><\/p>\n

Cloud API<\/p>\n

Traditional API<\/p>\n

 <\/p>\n

Segment by Application<\/strong><\/p>\n

SMS Aggregators<\/p>\n

Bulk SMS Providers<\/p>\n

Marketers\/Resellers<\/p>\n

Telecom Operators<\/p>\n

View Detailed Report at <\/strong>https:\/\/www.wiseguyreports.com\/reports\/3869258-global-dairy-nutrition-market-research-report-2019<\/a><\/p>\n

Table of Contents<\/strong><\/p>\n

Executive Summary<\/p>\n

1 Depression Therapeutics Market Overview<\/p>\n

1.1 Product Overview and Scope of Depression Therapeutics<\/p>\n

1.2 Depression Therapeutics Segment by Type<\/p>\n

1.2.1 Global Depression Therapeutics Production Growth Rate Comparison by Type (2014-2025)<\/p>\n

1.2.2 Selective Serotonin Reuptake Inhibitors (SSRIs)<\/p>\n

1.2.3 Selective Norepinephrine Reuptake Inhibitors (SNRIs)<\/p>\n

1.2.4 Others<\/p>\n

1.3 Depression Therapeutics Segment by Application<\/p>\n

1.3.1 Depression Therapeutics Consumption Comparison by Application (2014-2025)<\/p>\n

1.3.2 Hospital Pharmacies<\/p>\n

1.3.3 Retail Pharmacies<\/p>\n

1.3.4 Online Pharmacies<\/p>\n

1.4 Global Application-to-Person (A2P) SMS and API Market by Region<\/p>\n

1.4.1 Global Application-to-Person (A2P) SMS and API Market Size Region<\/p>\n

1.4.2 North America Status and Prospect (2014-2025)<\/p>\n

1.4.3 Europe Status and Prospect (2014-2025)<\/p>\n

1.4.4 China Status and Prospect (2014-2025)<\/p>\n

1.4.5 Japan Status and Prospect (2014-2025)<\/p>\n

1.5 Global Application-to-Person (A2P) SMS and API Market Size<\/p>\n

1.5.1 Global Depression Therapeutics Revenue (2014-2025)<\/p>\n

1.5.2 Global Depression Therapeutics Production (2014-2025)<\/p>\n

 <\/p>\n

2 Global Application-to-Person (A2P) SMS and API Market Competition by Manufacturers<\/p>\n

2.1 Global Depression Therapeutics Production Market Share by Manufacturers (2014-2019)<\/p>\n

2.2 Global Depression Therapeutics Revenue Share by Manufacturers (2014-2019)<\/p>\n

2.3 Global Depression Therapeutics Average Price by Manufacturers (2014-2019)<\/p>\n

2.4 Manufacturers Depression Therapeutics Production Sites, Area Served, Product Types<\/p>\n

2.5 Depression Therapeutics Market Competitive Situation and Trends<\/p>\n

2.5.1 Depression Therapeutics Market Concentration Rate<\/p>\n

2.5.2 Depression Therapeutics Market Share of Top 3 and Top 5 Manufacturers<\/p>\n

2.5.3 Mergers & Acquisitions, Expansion<\/p>\n

………………………………<\/p>\n

………………………………<\/p>\n

7 Company Profiles and Key Figures in Depression Therapeutics Business<\/p>\n

7.1 Pfizer, Inc<\/p>\n

7.1.1 Pfizer, Inc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.1.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.1.3 Pfizer, Inc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.1.4 Main Business and Markets Served<\/p>\n

7.2 Eli Lilly and Company<\/p>\n

7.2.1 Eli Lilly and Company Depression Therapeutics Production Sites and Area Served<\/p>\n

7.2.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.2.3 Eli Lilly and Company Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.2.4 Main Business and Markets Served<\/p>\n

7.3 AstraZeneca, Plc<\/p>\n

7.3.1 AstraZeneca, Plc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.3.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.3.3 AstraZeneca, Plc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.3.4 Main Business and Markets Served<\/p>\n

7.4 Allergan Plc<\/p>\n

7.4.1 Allergan Plc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.4.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.4.3 Allergan Plc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.4.4 Main Business and Markets Served<\/p>\n

7.5 GlaxoSmithKline Plc<\/p>\n

7.5.1 GlaxoSmithKline Plc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.5.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.5.3 GlaxoSmithKline Plc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.5.4 Main Business and Markets Served<\/p>\n

7.6 Intellipharmaceutics International, Inc<\/p>\n

7.6.1 Intellipharmaceutics International, Inc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.6.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.6.3 Intellipharmaceutics International, Inc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.6.4 Main Business and Markets Served<\/p>\n

7.7 Takeda Pharmaceutical Company Limited<\/p>\n

7.7.1 Takeda Pharmaceutical Company Limited Depression Therapeutics Production Sites and Area Served<\/p>\n

7.7.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.7.3 Takeda Pharmaceutical Company Limited Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.7.4 Main Business and Markets Served<\/p>\n

7.8 H.Lundbeck A\/S<\/p>\n

7.8.1 H.Lundbeck A\/S Depression Therapeutics Production Sites and Area Served<\/p>\n

7.8.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.8.3 H.Lundbeck A\/S Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.8.4 Main Business and Markets Served<\/p>\n

7.9 Otsuka Holdings Co.,Ltd<\/p>\n

7.9.1 Otsuka Holdings Co.,Ltd Depression Therapeutics Production Sites and Area Served<\/p>\n

7.9.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.9.3 Otsuka Holdings Co.,Ltd Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.9.4 Main Business and Markets Served<\/p>\n

7.10 Apotex, Inc<\/p>\n

7.10.1 Apotex, Inc Depression Therapeutics Production Sites and Area Served<\/p>\n

7.10.2 Depression Therapeutics Product Introduction, Application and Specification<\/p>\n

7.10.3 Apotex, Inc Depression Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)<\/p>\n

7.10.4 Main Business and Markets Served<\/p>\n

7.11 Shionogi & Co. Ltd<\/p>\n

7.12 Zhejiang Hua Hai Pharmaceutical Co., Ltd<\/p>\n

7.13 Chengdu Kanghong Pharmaceutical Group<\/p>\n

 <\/p>\n

8 Depression Therapeutics Manufacturing Cost Analysis<\/p>\n

8.1 Depression Therapeutics Key Raw Materials Analysis<\/p>\n

8.1.1 Key Raw Materials<\/p>\n

8.1.2 Price Trend of Key Raw Materials<\/p>\n

8.1.3 Key Suppliers of Raw Materials<\/p>\n

8.2 Proportion of Manufacturing Cost Structure<\/p>\n

8.3 Manufacturing Process Analysis of Depression Therapeutics<\/p>\n

8.4 Depression Therapeutics Industrial Chain Analysis<\/p>\n

……………………………………………….<\/p>\n

About Us:<\/strong><\/p>\n

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.   <\/p>\n

Contact Us:<\/strong><\/p>\n

NORAH TRENT                                                      <\/strong><\/p>\n

sales@wiseguyreports.com<\/a>       <\/strong><\/p>\n

Ph: +1-646-845-9349 (US)                          <\/strong><\/p>\n

Ph: +44 208 133 9349 (UK)      <\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com<\/a>
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

A2P SMS is currently used for various applications, such as providing event subsidies to end users, location-based opportunities, First-hand\/news news, promotional brands, voting contests, and transactional news for major industry vertical industries such as financial institutions and banks, games, travel … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-348380","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/348380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=348380"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/348380\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=348380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=348380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=348380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}